Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 5 of 5 entries
View as:

A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Phase: N/A Priority: Normal
NCT ID: NCT05128344 Org: User:
Start: 04/30/23 End: 12/31/25 Due: 12/31/26

Comparison of Diclofenac Systemic Exposure from Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.

Phase: N/A Priority: Normal
NCT ID: NCT06729073 Org: User:
Start: 11/29/24 End: 06/30/25 Due: 06/30/26

Bioavailability and Safety Study Comparing Two Dose Levels of AMZ001 and One Dose Level of Diclofenac Sodium 1% Gel in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05968482 Org: User:
Start: 07/11/23 End: 12/02/24 Due: 12/02/25

A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT06693648 Org: User:
Start: 02/18/25 End: 03/31/26 Due: 03/31/27

AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT03691844 Org: User:
Start: 10/04/18 End: 07/09/19 Due: 07/09/20